Panagora Asset Management’s Precision BioSciences DTIL Stock Holding History

Panagora Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,494	Closed	-$323K	–	1505
2022 Q1	$323K	Sell	3,494 -2,514	-42%	-$342K	﹤0.01%	1340
2021 Q4	$1.33M	Buy	6,008 +607	+11%	+$170K	0.01%	800
2021 Q3	$1.87M	Buy	5,401 +103	+2%	+$34.9K	0.01%	709
2021 Q2	$1.99M	Buy	5,298 +4,658	+728%	+$1.4M	0.01%	707
2021 Q1	$199K	Hold	640	–	–	﹤0.01%	1719
2020 Q4	$160K	Buy	640 +22	+4%	+$5.39K	﹤0.01%	1671
2020 Q3	$114K	Hold	618	–	–	﹤0.01%	1753
2020 Q2	$155K	Sell	618 -21	-3%	-$4.6K	﹤0.01%	1638
2020 Q1	$116K	Buy	639 +619	+3,095%	+$162K	﹤0.01%	1643
2019 Q4	$8K	Hold	20	–	–	﹤0.01%	2154
2019 Q3	$5K	Buy	+20	New	+$6.51K	﹤0.01%	2279

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Panagora Asset Management's DTIL Position: Q2 2022 in Review

Panagora Asset Management sold out of Precision BioSciences (DTIL) in Q2 2022, closing a stake of 3,494 shares — an estimated $323K sold.

Panagora Asset Management first reported a position in DTIL in Q3 2019 and held it in 11 quarters. The position peaked at $1.99M in Q2 2021. 119 funds tracked by Wall St. Rank hold DTIL as of Q2 2022.

Panagora Asset Management reported no remaining Precision BioSciences position as of Q2 2022 after selling out during the quarter.
Panagora Asset Management sold 3,494 Precision BioSciences shares in Q2 2022, an estimated $323K.
Panagora Asset Management first reported a position in Precision BioSciences in Q3 2019 and held it in 11 quarters.
Panagora Asset Management's Precision BioSciences position peaked at $1.99M in Q2 2021.
119 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.